The XPDGln751Lys polymorphism had no significant association with a reduced SPC risk from our meta-analysis, despite the fact that XPD gene, acting as a key DNA repair protein in the NER pathway, is involved in cancer pathogenesis. The gene discussed is ERCC2; the disease is cancer.